Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 1 , Pages 8-21 , March 2006

Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles

  • Catarina Pinto Reis, PhD

      Affiliations

    • Laboratório Tecnologia Farmacêutica, Faculdade de Farmácia, Universidade de Coimbra, Coimbra, Portugal
    • ,
  • Ronald J. Neufeld, PhD

      Affiliations

    • Chemical Engineering Department, Queen’s University, Kingston, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Chemical Engineering Department, Dupuis Hall, Queens University, Kingston, Ontario, Canada K7L3N6.
    • ,
  • António J. Ribeiro,, PhD

      Affiliations

    • Departamento Tecnologia Farmacêutica, I.S.C.S.N., Gandra, Paredes, Portugal
    • ,
  • Francisco Veiga, PhD

      Affiliations

    • Laboratório Tecnologia Farmacêutica, Faculdade de Farmácia, Universidade de Coimbra, Coimbra, Portugal

Received 21 August 2005 ,Accepted 20 December 2005.

References 

  1. Couvreur P, Dubernet C, Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm. 1995;41:2–13
  2. Couvreur P. Polyalkylcyanoacrylates as colloidal drug carriers. Crit Rev Ther Drug Carrier Syst. 1988;5:1–20
  3. Allémann E, Gurny R, Doekler E. Drug-loaded nanoparticles-preparation methods and drug targeting issues. Eur J Pharm Biopharm. 1993;39:173–191
  4. McClean S, Prosser E, Meehan E, O'Malley D, Clarke N, Ramtoola Z, et al. Binding and uptake of biodegradable poly-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci. 1998;6:153–163
  5. Benoit JP, Couvreur P, Devissaguet J-P, Fessi H, Puisieux F, Roblot-Treupel L. Les formes vectorisées ou distribution modulée, nouveuax sistèmes d'administration medicaments. J Pharm Belg. 1986;41:319–329
  6. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1–20
  7. Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur J Pharm Biopharm. 2000;50:147–160
  8. Kumar N, Ravikumar MNV, Domb AJ. Biodegradable block copolymers. Adv Drug Deliv Rev. 2001;53:23–44
  9. Kreuter J. Large-scale production problems and manufacturing of nanoparticles. In:  Tyle P editors. Specialized drug delivery system. New York: Marcel Dekker; 1990;p. 257–266
  10. Ekman B, Sjöholm I. Improved stability of proteins immobilized in microparticles prepared by modified emulsion polymerization technique. J Pharm Sci. 1978;67:693–696
  11. Lowe PJ, Temple CS. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J Pharm Pharmacol. 1994;46:547–552
  12. Kreuter J. Nanoparticle-based drug delivery systems. J Control Release. 1991;16:169–176
  13. El-Samaligy MS, Rohdewald P, Mahmoud HA. Polyalkylcyanoacrylate nanocapsules. J Pharm Pharmacol. 1986;38:216–218
  14. Krause HJ, Schwarz A, Rohdewald P. Interfacial polymerization, an useful method for the preparation of polymethylcyanoacrylate nanoparticles. Drug Dev Ind Pharm. 1986;12:527–552
  15. Harmia-Pulkkinen T, Tuomi A, Kristoffersson E. Manufacture of polyalkylcyanoacrylate nanoparticles with pilocarpine and timolol by micelle polymerization: factors influencing particle formation. J Microencapsul. 1989;6:87–93
  16. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev. 2003;55:519–548
  17. Kreuter J. The mechanism of termination in heterogeneous polymerization. J Polym Sci. 1982;20:543–545
  18. Kreuter J, Speiser P. New adjuvants on a polymethyl(methacrylate) base. Infect Immun. 1976;13:204–210
  19. Kreuter J. Evaluation of nanoparticles as drug-delivery system. I. Preparation methods. Pharm Acta Helv. 1983;58:196–209
  20. Rolland A, Gibassier D, Sado P, Le Verge R. Purification et propriétés physico-chimiques des suspensions de nanoparticules de polymère. J Pharm Belg. 1986;41:94–105
  21. Kreuter J, Täuber U, Illi V. Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice. J Pharm Sci. 1979;68:1443–1447
  22. Grislain L, Couvreur P, Lenaerts V, Roland M, Deprez-Decampeneere D, Speiser PP. Pharmacokinetics and distribution of a biodegradable drug-carrier. Int J Pharm. 1983;15:335–345
  23. Kreuter J. Nanoparticles—preparation and applications. In:  Donbrow M editors. Microcapsules and nanoparticles in medicine and pharmacy. London: CRC Press Boca Raton; 1992;p. 125–148
  24. Seijo B, Fattal E, Roblot-Treupel L, Couvreur P. Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. Int J Pharm. 1990;62:1–7
  25. Némati F, Dubernet C, Fessi H, Verdière AC, Poupon MF, Puisieux F, et al. Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer. Int J Pharm. 1996;138:237–246
  26. Bapat N, Boroujerdi M. Uptake capacity and adsorption isotherms of doxorubicin on polymeric nanoparticles: effect of methods of preparation. Drug Dev Ind Pharm. 1992;18:65–77
  27. Li VHK, Wood RW, Kreuter J, Harmia T, Robinson JR. Ocular drug delivery of progesterone using nanoparticles. J Microencapsul. 1986;3:213–218
  28. El-Samaligy MS, Rohdewald P. Triamcinolone diacetate nanoparticles a sustained release drug delivery system suitable for parental administration. Pharm Acta Helv. 1982;57:201–204
  29. Michel C, Roques M, Couvreur P, Vranchx H, Baldschmidt P. Isobutylcyanoacrylate nanoparticles as drug carrier for oral administration of insulin. Proc Int Symp Control Release Bioact Mater. 1991;18:97–98
  30. Grangier JL, Puygrenier M, Gauthier JC, Couvreur P. Nanoparticles as carriers for growth hormone releasing factors (GRF). J Control Release. 1991;15:3–13
  31. Kubiak C, Manil L, Couvreur P. Sorptive properties of antibodies onto cyanoacrylic nanoparticles. Int J Pharm. 1988;41:181–187
  32. Lescure F, Zimmer C, Roy D, Teulon JM, Couvreur P. Synthesis and evaluation of a new biodegradable monomer. Proc Int Symp Contr Rel Bioact Matter. 1991;18:325–326
  33. Mbela TKM, Poupaert JH, Dumont P. Poly(diethylmethyldene malonate) nanoparticles as primaquine delivery system to liver. Int J Pharm. 1992;79:29–38
  34. Couvreur P, Barrat G, Fattal E, Legrand P, Vauthier C. Nanocapsule technology. Crit Rev Ther Drug Carrier Syst. 2002;19:99–134
  35. Al Khouri N, Roblot-Treupel L, Fessi H, Devissaguet JP, Puisieux F. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int J Pharm. 1986;28:125–132
  36. Watnasirichaikul S, Davies NM, Rades T, Tucker IG. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm Res. 2000;17:684–689
  37. Aprahamian M, Michel C, Humbert W, Devissaguet J-P, Damgé C. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol Cell. 1987;61:69–76
  38. Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm Res. 2000;17:707–714
  39. Lenaerts V, Labib A, Chouinard F, Rousseau J, Ali H, Lier J. Nanocapsules with a reduced liver uptake: targeting of phthalocyanines to EMT-6 mouse mammary tumour in vivo. Eur J Pharm Biopharm. 1995;41:38–43
  40. Damgé C, Michel C, Aprahamian M, Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes. 1988;37:246–251
  41. Damgé C, Vonderscher J, Marbach P, Pinget M. Poly(alkylcyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue. J Pharm Pharmacol. 1997;49:949–954
  42. Hubert B, Atkinson J, Guerret M, Hoffman M, Devissaguet J-P, Maincent P. The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker. Pharm Res. 1991;8:734–738
  43. Gürsoy A, Eroglu L, Ulutin S, Tasyürek M, Fessi H, Puisieux F, et al. Evaluation of indomethacin nanocapsules for their physical stability and inhibitory activity on inflammation and platelet aggregation. Int J Pharm. 1989;52:101–108
  44. Ammoury N, Fessi H, Devissaguet J-P, Dubrasquet M, Benita S. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutylcyanoacrylate) nanocapsules in rats. Pharm Res. 1991;8:101–105
  45. Vranchx H, Demoustier M, Deleers M. A new nanocapsule formulation with hydrophilic core: application to the oral administration of salmon calcitonin. Eur J Pharm Sci. 1996;42:345–347
  46. Vranchx H,Demoustier M,Deleers M. Pharmaceutical compositions containing nanocapusles. US Patent 5.500.224. 1996.
  47. Allémann E, Leroux JC, Gurny R. Polymeric nano-microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Deliv Rev. 1998;34:171–189
  48. Montasser I, Fessi H, Coleman AW. Atomic force microscopy imaging of novel type of polymeric colloidal nanostructures. Eur J Pharm Biopharm. 2002;54:281–284
  49. Bouchemal K, Briancon S, Perrier E, Fessi H, Bonnet I, Zydowicz N. Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. Int J Pharm. 2004;269:89–100
  50. Tice TR, Gilley RM. Preparation of injectable controlled-release microcapsules by solvent-evaporation process. J Control Release. 1985;2:343–352
  51. Aftabrouchard D, Dorlker E. Preparation methods for biodegradable microparticles loaded with water-soluble drugs. STP Pharma Sci. 1992;2:365–380
  52. Gurny R, Peppas NA, Harrington DD, Banker GS. Development of biodegradable and injectable lattices for controlled release of potent drugs. Drug Dev Ind Pharm. 1981;7:1–25
  53. Ueda H, Kreuter J. Optimization of the preparation of loperamide-loaded poly (l-lactide) nanoparticles by high pressure emulsification solvent evaporation. J Microencapsul. 1997;14:593–605
  54. Tabata J, Ikada Y. Protein pre-coating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. Pharm Res. 1989;6:296–301
  55. Bodmeier R, Chen H. Indomethacin polymeric nanosuspensions prepared by microfluidization. J Control Release. 1990;12:223–233
  56. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long circulating nanospheres. Science. 1994;263:1600–1603
  57. Kumar MVR. Nano and microparticles as controlled drug delivery devices. J Pharm Sci. 2000;3:234–258
  58. Lemarchand C, Gref R, Passirani C, Garcion E, Petri B, Muller R. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials. 2006;27:108–118
  59. Koosha F, Muller RH, Washington C. Production of polyhydroxybutyrate (PHB) nanoparticles for drug targeting. J Pharm Pharmacol. 1987;39:136P
  60. Koosha F, Muller RH, Davis SS, Davies MC. The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process. J Control Release. 1989;9:149–157
  61. Landry FB, Bazile DV, Spenlehauer G, Veillard M, Kreuter J. Influence of coating agents on the degradation of poly(d,l-lactic acid) nanoparticles in model digestive fluids (USP XXII). STP Pharma Sci. 1996;6:195–202
  62. Tobío M, Gref R, Sánchez A, Langer R, Alonso MJ. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res. 1998;15:270–275
  63. Ueda M, Iwara A, Kreuter J. Influence of the preparation methods on the drug release behavior of loperamide-loaded nanoparticles. J Microencapsul. 1998;15:361–372
  64. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290:137–144
  65. Jaiswal J, Gupta SK, Kreuter J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J Control Release. 2004;96:169–178
  66. Sánchez A, Vila Jato JL, Alonso MJ. Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporine. Int J Pharm. 1993;99:263–273
  67. Prabha S, Zhou W-Z, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection studies with fractionated nanoparticles. Int J Pharm. 2002;244:105–115
  68. Fessi H, Puisieux F, Devissaguet J-P, Ammoury N, Benita S. Nanocapsule formation by interfacial deposition following solvent displacement. Int J Pharm. 1989;55:R1–R4
  69. Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm. 1999;25:471–476
  70. Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res. 2004;21:1428–1439
  71. Ganachaud F, Katz JL. Nanoparticles and nanocapsules created using the ouzo effect: Spontaneous emulsification as an alternative to ultrasonic and high-shear devices. Chem Phys Chem. 2005;6:209–216
  72. Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998;24:1113–1128
  73. Dimitrova B, Ivanov IB, Nakache E. Mass transport effects on the stability of emulsion films with acetic acid and acetone diffusing across the interface. J Disp Sci Technol. 1988;9:321–341
  74. Wehrle P, Magenheim B, Benita S. Influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design. Eur J Pharm Biopharm. 1995;41:19–26
  75. Molpeceres J, Guzman M, Aberturas MR, Chacon M, Berges L. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. J Pharm Sci. 1996;85:206–213
  76. Irache JM, Huici M, Konecny M, Espuelas S, Campanero MA, Arbos P. Bioadhesive properties of gantrez nanoparticles. Molecules. 2005;10:126–145
  77. Arbós P, Wirth M, Arangoa MA, Gabor F, Irache JM, Gantrez . Gantrez®AN as a new polymer for the preparation of ligand-nanoparticle conjugates. J Control Release. 2002;83:321–330
  78. Memisoglu E, Bochot A, Özalp M, Sen M, Duchêne D, Hincal A. Direct formation of nanospheres from amphiphilic beta-cyclodextrin inclusion complexes. Pharm Res. 2003;20:117–125
  79. Ammoury N, Fessi H, Devissaguet J-P, Puisieux F, Benita S. In vitro release pattern of indomethacin from poly(d,l-lactide) nanocapsules. J Pharm Sci. 1990;79:763–767
  80. Vargas A, Pegaz B, Debefve E, Konan-Kouakou Y, Lange N, Ballini J-P, et al. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int J Pharm. 2004;286:131–145
  81. Konan YN, Gurny R, Allémann E. State of the art in the delivery of photosensibilizers for photodynamic therapy. Photochem Photobiol B. 2002;66:89–106
  82. Yoo HS, Oh JE, Lee KH, Park TG. Biodegradable nanoparticles containing PLGA conjugate for sustained release. Pharm Res. 1999;16:1114–1118
  83. Perez C, Sánchez A, Putnam D, Ting D, Langer R, Alonso MJ. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release. 2001;75:211–224
  84. Lu W, Zhang Y, Tan Y-Z, Hu K-L, Jiang X-G, Fu S-K. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release. 2005;107:428–448
  85. Saxena V, Sadoqi M, Shao J. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Int J Pharm. 2004;278:293–301
  86. El-Shabouri MH. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm. 2002;249:101–108
  87. Lambert G, Fattal E, Couvreur P. Nanoparticulate system for the delivery of antisense oligonucleotides. Adv Drug Deliv Rev. 2001;47:99–112
  88. Patil GV. Biopolymer albumin for diagnosis and in drug delivery. Drug Dev Res. 2003;58:219–247
  89. Widder KJ, Flouret G, Senye A. Magnetic microspheres: synthesis of a novel parenteral drug carrier. J Pharm Sci. 1979;68:79–82
  90. Marty JJ, Oppenheim RC, Speiser P. Nanoparticles—a new colloidal drug system delivery system. Pharm Acta Helv. 1978;53:17–23
  91. Longo WE, Iwata H, Lindheimer TA, Goldberg EP. Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. J Pharm Sci. 1982;71:1323–1328
  92. Yoshioka T, Hashida M, Muranishi S, Sezaki H. Specific delivery of mitomycin C to the liver, spleen, and lung: nano- and microspherical carriers of gelatin. Int J Pharm. 1981;8:131–141
  93. Duclairoir C, Orecchioni AM, Depraetere P, Nakache E. α-Tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles. J Microencapsul. 2002;19:53–60
  94. Aslani P, Kennedy RA. Studies on diffusion in alginate gels. I. Effect of cross-linking with calcium or zinc ions on diffusion of acetaminophen. J Control Release. 1996;42:75–82
  95. Kwok KK, Groves MJ, Burgess DJ. Production of 5-15 μm diameter alginate-polylysine microcapsules by an air atomization technique. Pharm Res. 1991;8:341–344
  96. Reis CP, Neufeld RJ, Ribeiro AJ, Viega F. Insulin-alginate nanospheres: influence of calcium on polymer matrix properties. In: Proceedings of the 13th International Workshop on Bioencapsulation; 2005; Queen's University Kingston, Ontario, Canada. 2005;
  97. Vila A, Sánchez A, Janes KA, Behrens I, Kissel T, Vila-Jato JL, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm. 2004;57:123–131
  98. Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release. 2001;73:255–267
  99. Ma Z, Lim TM, Lim L-Y. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm. 2005;293:271–280
  100. Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm. 2004;57:1–8
  101. Mao H-Q, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70:399–421
  102. Illum L, Farraj NF, Davis SS. Chitosan as novel nasal delivery system for peptide drugs. Pharm Res. 1994;11:1186–1189
  103. Calvo P, Remuñan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997;14:1431–1436
  104. Tokumitsu H, Ichikawa H, Fukumori Y, Hiratsuka J, Sakurai Y, Kobayashi T. Preparation of gadopentetate-loaded chitosan nanoparticles for gadolinium neutron capture therapy of cancer using a novel emulsion droplet coalescence technique. In: Proceedings of the 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, APGI/APV; Paris. 1998;p. 641–642
  105. Aktas Y, Andrieux K, Alonso MJ, Calvo P, Gürsoy RN, Couvreur P. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int J Pharm. 2005;298:378–383
  106. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 2004;100:5–28
  107. Vauthier C, Couvreur P. Development of polysaccharide nanoparticles as novel drug carrier systems. In:  Wise DL editors. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000;p. 413–429
  108. Wang N, Wu XS, Mesiha M. A new method for preparation of protein-loaded agarose nanoparticles. Pharm Res. 1995;12:S257
  109. Wang N, Wu XS. Preparation and characterization of agarose hydrogel nanoparticles for protein and peptide drug delivery. Pharm Dev Technol. 1997;2:135–142
  110. Ibrahim H, Bindschaedler C, Doelker E, Buri P, Gurny R. Aqueous nanodispersions prepared by a salting-out process. Int J Pharm. 1992;87:239–246
  111. Marty JJ. The preparation, purification and properties of nanoparticles. D. Pharm Thesis Parkville (Australia): Victorian College of Pharmacy; 1977, p. 30.
  112. Weber C, Coester C, Kreuter J, Langer R. Desolvation process and surface characterization of protein nanoparticles. Int J Pharm. 2000;194:91–102
  113. El-Samaligy MS, Rohdewald P. Reconstituted collagen nanoparticles, a novel drug carrier delivery system. J Pharm Pharmacol. 1983;35:537–539
  114. Coester C, Langer K, Briesen HV, Kreuter J. Gelatin nanoparticles by two step desolvation—a new preparation method, surface modifications and cell uptake. J Microencapsul. 2000;17:187–193
  115. Zillies J, Coester C. Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides. J Pharm Pharm Sci. 2004;7:17–21
  116. Zwiorek K, Kloeckner J, Qagner E, Coester C. Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharm Sci. 2004;7:22–28
  117. Lu Z, Yeh T-K, Tsai M, Au JL-S, Wientjes MG. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res. 2004;10:7677–7684
  118. Caliceti P, Salmaso S, Elvassore N, Bertucco A. Effective protein release from PEG/PLA nanoparticles produced by compressed gas anti-solvent precipitation techniques. J Control Release. 2004;94:195–205
  119. Wang Y, Dave RN, Pfeffer R. Polymer coating/encapsulation of nanoparticles using a supercritical anti-solvent process. J Supercrit Fluids. 2004;28:85–99
  120. Esquisabel A, Hernández RM, Igartua M, Gascón AR, Calvo B, Pedraz JL. Production of BCG alginate-PLL microcapsules by emulsification/internal gelation. J Microencapsul. 1997;14:627–638
  121. Kreuter J, Mauler R, Gruschkau H, Speiser PP. The use of new polymethylmethacrylate adjuvants for split influenza vaccines. Exp Cell Biol. 1976;44:12–19
  122. Couvreur P, Kante B, Lenaerts V, Scailteur V, Roland M, Speiser P. Tissue distribution of antitumour drugs associated with polyalkylcyanoacrylate nanoparticles. J Pharm Sci. 1980;69:199–202
  123. Radwan MA, Aboul-Enein HY. The effect of the oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J Microencapsul. 2002;19:225–235
  124. Maincent P, Le Verge R, Sado P, Couvreur P, Devissaguet J-P. Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles. J Pharm Sci. 1986;75:955–958
  125. Arbós P, Campanero MA, Arangoa MA, Renedo MJ, Irache JM. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J Control Release. 2003;89:19–30
  126. Allémann E, Leroux JC, Gurny R, Doekler E. In vitro extended-release properties of drug-loaded poly(d,l-lactic acid) nanoparticles produced by salting-out procedure. Pharm Res. 1993;10:1732–1737
  127. Konan YN, Berton M, Gurny R, Allémann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci. 2003;18:241–249
  128. Aynié I, Vauthier C, Fattal E, Puisieux F, Couvreur P. Role of a small polylysine in a hydrogel nanoparticulate system for the antisense oligonucleotide strategy. In: Proceedings of the 2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, APGI/APV; Paris. 1998;p. 583–584
  129. Aynié I, Vauthier C, Fattal E, Foulquier M, Couvreur P. Alginate nanoparticles as a novel carrier for antisense oligonucleotides. In:  Muller H editors. Future strategies for drug delivery with particulate systems. Boca Raton (FL): CRC Press; 1998;p. 11–16
  130. Elvassore N, Bertucco A, Caliceti P. Production of insulin-loaded poly(ethylene glycol)/poly(l-Lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. J Pharm Sci. 2001;90:1628–1636

PII: S1549-9634(06)00005-0

doi: 10.1016/j.nano.2005.12.003

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 1 , Pages 8-21 , March 2006

Article Tools

* Image Usage & Resolution